Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia
Clinical trial NCT03519464 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03519464
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-04
- Primary completion
- 2026-12-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.